Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
Review article, 2008
prevention & control
physiopathology
metabolism
metabolism
metabolism
VLDL
etiology
Metabolic Syndrome X
blood
physiopathology
Dyslipidemias
metabolism
Up-Regulation
Humans
Insulin Resistance
Lipoproteins
Type 2
drug therapy
therapeutic use
Diabetes Mellitus
Triglycerides
blood
metabolism
metabolism
drug therapy
Fatty Acids
complications
Antilipemic Agents
Liver
Disease Progression
metabolism
Author
Martin Adiels
University of Gothenburg
Sven-Olof Olofsson
University of Gothenburg
Marja-Riitta Taskinen
Jan Borén
University of Gothenburg
Arteriosclerosis, Thrombosis, and Vascular Biology
1079-5642 (ISSN) 1524-4636 (eISSN)
Vol. 28 7 1225-36Subject Categories
MEDICAL AND HEALTH SCIENCES
DOI
10.1161/ATVBAHA.107.160192
PubMed
18565848